Canary Speech and Prism Care Announce Partnership to Enhance Extended Care Through Vocal Biomarker Technology
December 19, 2024
PROVO, UT, Dec. 17, 2024 – Canary Speech, Inc., a leader in AI-driven vocal biomarker technology, and Prism Care, Inc., a provider of comprehensive extended care management solutions, have announced a strategic partnership to enhance patient care through vocal biomarker technology. Together, the companies aim to set new standards for managing mental health and cognitive conditions with tools that seamlessly integrate into existing provider workflows, enabling faster, data-driven decisions for providers and their patients.
By partnering with Canary Speech, Prism Care will integrate groundbreaking vocal biomarker analysis into its extended care system, enhancing its ability to deliver superior patient outcomes.
This collaboration marks a pivotal step toward addressing the growing demand for innovative care models that prioritize both efficacy and accessibility and underscores both companies’ missions to leverage cutting-edge technology in service of better healthcare outcomes.
“We are fortunate to form a strategic partnership with Canary Speech,” said Kerry Brooks, co-founder, CEO and Chairman of Prism Care. “Their vocal biomarker analysis combined with our comprehensive extended care system creates an unmatched platform to manage important conditions like anxiety, depression, and cognitive decline.”
“We are thrilled to partner with Prism Care,” said Henry O’Connell, co-founder and CEO of Canary Speech. “Our shared commitment to innovation and patient-first solutions aligns perfectly. Integrating Canary’s technology into Prism Care’s platform will unlock new possibilities for early detection and intervention, ultimately transforming extended care.”
Founded in 2019, Prism Care is renowned for its nurse-led, high-touch connectivity and advanced medical technology that bridges care between provider visits. Prism Care’s nurse-led approach and Canary Speech’s AI technology together offer a powerful solution to improve care quality and patient experience, especially for vulnerable populations.
About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary’s vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia. Canary Speech is a Utah-based company that advances speech and language applications for health systems, payers and pharmaceutical markets.
About Prism Care, Inc.
Prism Care is a rapidly growing leader in comprehensive extended care solutions. Founded in 2019, the company combines nurse-led, high-touch connectivity with advanced medical technology to deliver industry-leading care between provider visits. This proprietary strategy drives superior patient engagement, satisfaction, and outcomes.
Contacts
Caitlyn Brooksby
VP Marketing & Strategic Partnerships Canary Speech
caitlyn@canaryspeech.com
Thomas Kramer
SVP Partnership Development Prism Care
Thomas.Kramer@PrismCare.com